New Jersey-based St. Joseph’s Hospital and Medical Center has purchased a comprehensive PACS from MediSolution. Installation will be completed through the Canadian company’s new MarkCare division, established after acquisition of a company by
New Jersey-based St. Joseph’s Hospital and Medical Center has purchased a comprehensive PACS from MediSolution. Installation will be completed through the Canadian company’s new MarkCare division, established after acquisition of a company by that name. The contract is expected to generate more than CDN $1.5 million in revenue for MediSolution’s MarkCare division over the next three years. In related news, MediSolution has completed its first PACS installation in Canada at Boundary Trails Health Centre, a newly completed medical facility in Winkler, Manitoba.
Could an Emerging PET Tracer be a Game Changer for Detecting Hepatocellular Carcinoma?
June 23rd 2025In addition to over 90 percent sensitivity in detecting hepatocellular carcinoma (HCC), the glypican-3 (GPC3) targeted PET tracer 68Ga-aGPC3-scFv appeared to be advantageous in identifying HCC tumors smaller than one centimeter, according to pilot study findings presented at the SNMMI conference.